Status:
TERMINATED
Treatment Resistant Bipolar Depression
Lead Sponsor:
Queen's University
Conditions:
Bipolar Depression
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
To determine if adding Escitalopram to current mood stabilizer (MS) or atypical antipsychotic (AA) will improve in rates similar to or better than adding a placebo (inactive pill)in resistant bipolar ...
Eligibility Criteria
Inclusion
- Age 18 or older
- Diagnosis of Bipolar Disorder and currently be in depressive state, and not responded to mood stabilizer or atypical antipsychotic alone or combined with an antidepressant medication.
Exclusion
- Pregnant or breastfeeding
- History of seizure disorder or other unstable medical condition
- Received Electroconvulsive Therapy or Transcranial Magnetic Stimulation in the last three months
- Experienced hallucinations or delusions
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT00272025
Start Date
October 1 2006
End Date
January 1 2010
Last Update
December 16 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Providence Care, Mental Health Services
Kingston, Ontario, Canada, K7L 4X3